Gender differences in systemic sclerosis: relationship to clinical features,serologic status and outcomes

Abstract

Introduction

There is a strong female preponderance reported in many connective tissue diseases and in almost all systemic sclerosis (SSc) case series.

Methods

We compared gender differences in SSc patients in a large single-center cohort, including demographic features, disease subtype, environmental exposures, disease-specific serum autoantibodies, organ system involvement (frequency and severity) and survival. Adjustment for cutaneous subset (diffuse cutaneous [dc] and limited cutaneous [lc]) was performed.

Results

We identified key characteristics which distinguished female from male SSc patients. Females were more frequently younger at disease onset with a longer disease duration at the time of their first visit. Females more often had lcSSc and, if an overlap syndrome was present, it was most often systemic lupus erythematosus. In contrast, males more frequently had dcSSc and overlap with myositis. Females more frequently had peripheral vascular involvement but in males it was more often severe. Males were more often cigarette smokers and more frequently had environmental exposures. Males more frequently had interstitial lung disease (ILD or pulmonary fibrosis) which was more severe. Females had a significantly increased frequency of anti-centromere antibody and males anti-topoisomerase I and anti-U3RNP antibody. Males had significantly reduced survival (73% at 5 years and 45% at 10 years after onset of SSc). The most frequent causes of death were ILD in males and pulmonary hypertension in females.

Conclusions

Gender differences may be important clues to understanding the natural history and pathogenesis of SSc.

Keywords

Gender Scleroderma Systemic sclerosis

Get full access to this article

View all access options for this article.

References

Steen

Oddis

Conte

Janoski

Casterline

Medsger

Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Arthritis Rheum 1997;40:(3)441-445

Medsger

Classification, prognosis. 2^nd ed.

In: Clements PJ, Furst DE, eds. Systemic sclerosis Philadelphia

Lippincott, Williams & Wilkins

2004:17-28.

Gaultier

Hot

Cathébras

Grange

Ninet

Rousset

[Systemic sclerosis in men].

Rev Med Interne 2008;29:(3)181-186

Steen

Medsger

Changes in causes of death in systemic sclerosis, 1972-2002.

Ann Rheum Dis 2007;66:(7)940-944

Bombardieri

Medsger

Jr Silman

Valentini

The assessment of the patient with systemic sclerosis.

Introduction. Clin Exp Rheumatol 2003;21 3 Suppl 29S2-S4

Clements

Feghali

Cutaneous involvement in systemic sclerosis.

Philadelphia

Lippincott Williams & Wilkins

2004.

Koschik

II Fertig

Lucas

Domsic

Medsger

Anti-PM-Scl antibody in patients with systemic sclerosis.

Clin Exp Rheumatol 2012;30 2 Suppl 71S12-S16

Clements

Lachenbruch

Siebold

et al.

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

J Rheumatol 1995;22:(7)1281-1285

Okano

Medsger

Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis.

Arthritis Rheum 1990;33:(12)1822-1828

10.

Okano

Steen

Medsger

Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis.

Arthritis Rheum 1992;35:(1)95-100

11.

Okano

Steen

Medsger

Autoantibody reactive with RNA polymerase III in systemic sclerosis.

Ann Intern Med 1993;119:(10)1005-1013

12.

Fertig

Domsic

Rodriguez-Reyna

et al.

Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.

Arthritis Rheum 2009;61:(7) 958-965

13.

Kaji

Fertig

Medsger

Jr et al.

Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.

Arthritis Care Res (Hoboken) 2014;66:(4)575-584

14.

Masi

Rodnan

Medsger

Jr et al.

Preliminary criteria for the classification of systemic sclerosis (scleroderma).

Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:(5)581-590

15.

LeRoy

Medsger

Criteria for the classification of early systemic sclerosis.

J Rheumatol 2001;28:(7)1573-1576

16.

van den Hoogen

Khanna

Fransen

et al.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Ann Rheum Dis 2013;72:(11)1747-1755

17.

Poormoghim

Lucas

Fertig

Medsger

Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.

Arthritis Rheum 2000;43:(2)444-451

18.

Freire

Simeon-Aznar

Rivera Gallego

et al.

Clinic and mortality differences between sclerodermic men and women of the Rescle Cohort.

Journal of Scleroderma and Related Disorders 2016;1:(1)151

19.

Sparks

Chang

Deane

et al.

Associations of smoking and age with inflammatory joint signs among first-degree relatives without rheumatoid arthritis: Results from the Studies of the Etiology of RA.

Arthritis Rheumatol 2016 Feb 11. doi: 10.1002/art.39630. [Epub ahead of print].

20.

Feghali-Bostwick

Medsger

Jr Wright

Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.

Arthritis Rheum 2003;48:(7)1956-1963

21.

Nguyen

Bérezné

Baubet

et al;

Groupe Français de Recherche sur la Sclérodermie.

Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS ONE 2011 6:(3)e17551

22.

Peters-Golden

Wise

Schneider

Hochberg

Stevens

Wigley

Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis.

Medicine (Baltimore) 1984;63:(4)221-231

23.

Wynn

Fineberg

Matzer

et al.

Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features.

Am Heart J 1985;110 1 Pt 1123-127

24.

Al-Dhaher

Pope

Ouimet

Determinants of morbidity and mortality of systemic sclerosis in Canada.

Semin Arthritis Rheum 2010;39:(4)269-277

25.

Ferri

Valentini

Cozzi

et al;

Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc).

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:(2)139-153

26.

Hesselstrand

Scheja

Akesson

Mortality and causes of death in a Swedish series of systemic sclerosis patients.

Ann Rheum Dis 1998;57:(11)682-686

27.

Crosslin

Wiginton

Sex differences in disease severity among patients with systemic lupus erythematosus.

Gend Med 2011;8:(6)365-371

28.

Schwartzman-Morris

Putterman

Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis.

Clin Dev Immunol 2012;2012604892

29.

de Carvalho

do Nascimento

Testagrossa

Barros

Bonfá

Male gender results in more severe lupus nephritis.

Rheumatol Int 2010;30:(10)1311-1315

30.

Gribbin

Hubbard

Le Jeune

Smith

CJP

West

Tata

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Thorax 2006;61:(11)980-985

31.

Aida-Yasuoka

Peoples

Yasuoka

et al.

Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis.

Arthritis Res Ther 2013;15:(1)R10

32.

Vermeulen

Kaufman

Goemaere

van Pottelberg

Estradiol in elderly men.

Aging Male 2002;5:(2)98-102

33.

Holmboe

Vradi

Jensen

et al.

The association of reproductive hormone levels and all-cause, cancer, and cardiovascular disease mortality in men.

J Clin Endocrinol Metab 2015 100:(12)4472-4480

34.

D'Amico

Skarmoutsou

Mazzarino

The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Clin Rev Allergy Immunol 2014;47:(3) 334-343

35.

Ozbalkan

Bagişlar

Kiraz

et al.

Skewed X chromosome inactivation in blood cells of women with scleroderma.

Arthritis Rheum 2005;52:(5)1564-1570

36.

Loubiere

Gadi

et al.

Skewed X-chromosome inactivation in scleroderma.

Clin Rev Allergy Immunol 2008;34:(3)352-355

37.

Broen

Wolvers-Tettero

Geurts-van Bon

et al.

Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis.

Ann Rheum Dis 2010;69:(12)2213-2216

38.

Lian

Xiao

et al.

DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility.

Arthritis Rheum 2012;64:(7) 2338-2345

39.

Selmi

Feghali-Bostwick

Lleo

et al.

X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma.

Clin Exp Immunol 2012;169:(3)253-262

40.

Hasegawa

Sato

Ihn

Takehara

Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.

Rheumatology (Oxford) 1999;38:(7)612-617

41.

Feghali

Bost

Boulware

Levy

Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.

J Rheumatol 1992;19:(8)1207-1211

42.

Rovenský

Imrich

Lazúrová

Payer

Rheumatic diseases and Klinefelter's syndrome.

Ann N Y Acad Sci 2010;1193:(1193)1-9

43.

Kobayashi

Shimamoto

Taniguchi

Hashimoto

Hirose

Klinefelter's syndrome associated with progressive systemic sclerosis: report of a case and review of the literature.

Clin Rheumatol 1991;10:(1)84-86

44.

Bargagli

Bartalini

Galeazzi

Maggiorelli

Anichini

Rottoli

Chromosome 5 inversion in two siblings, one with Klinefelter syndrome and systemic sclerosis, the other with rheumatoid arthritis.

Rheumatol Int 2008;28:(7)725-726

45.

De Keyser

Mielantes

Veys

Klinefelter's syndrome and scleroderma.

J Rheumatol 1989;16:(12)1613-1614

46.

Velasco

Savarese

Sandorfi

Jimenez

Jabbour

46, XX SRY-positive male syndrome presenting with primary hypogonadism in the setting of scleroderma.

Endocr Pract 2011;17:(1)95-98